Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Spectrum meets with FDA regarding Fusilev sNDA for colorectal cancer

Jan. 26, 2010

Merck KGaA claims tyrosine kinase inhibitors for the treatment of cancer

Jan. 26, 2010

Clinical data show safety and efficacy of dasatinib as initial therapy for CML

Jan. 26, 2010

Clinical data shows nilotinib to be an effective front-line treatment for CML

Jan. 26, 2010

OVATURE trial analysis to proceed following database lock

Jan. 25, 2010

Agennix expands phase III talactoferrin registration trial globally

Jan. 25, 2010

Cetuximab as first-line therapy for Menetrier's disease / News in Context

Jan. 25, 2010

ACT Biotech confirms FDA acceptance of ACTB-1003 IND

Jan. 25, 2010

Sunesis completes enrollment of phase Ib/II voreloxin trial

Jan. 25, 2010

Bayer Schering Pharma discovers novel c-Met inhibitors for cancer therapy

Jan. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...